Ambeed 大中华区 CN | ZH

中文 - ZH English - EN

Ambeed.cn

搜索

关键字搜索批量搜索

首页 收藏 购物车0
首页 /
抑制剂/激动剂
囊泡
/
G蛋白偶联受体/G蛋白
神经信号通路 帕金森与阿尔茨海默症
/
DAT
多巴胺受体
/ Oxidopamine hydrobromide

6-羟基多巴胺氢溴酸盐 /Oxidopamine hydrobromide {[allProObj[0].p_purity_real_show]}

货号：A818244 同义名： 6-Hydroxydopamine hydrobromide;6-OHDA hydrobromide Ambeed 开学季，买赠积分，赢豪礼

Oxidopamine hydrobromide is a selective catecholaminergic neurotoxin, depletes brain catecholamine levels via uptake and accumulation by a transport mechanism specific to these neurons.

Oxidopamine hydrobromide 化学结构 CAS号：636-00-0
Oxidopamine hydrobromide 化学结构
CAS号：636-00-0
Oxidopamine hydrobromide 3D分子结构
CAS号：636-00-0
Oxidopamine hydrobromide 化学结构 CAS号：636-00-0
Oxidopamine hydrobromide 3D分子结构 CAS号：636-00-0
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} 		{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Oxidopamine hydrobromide 纯度/质量文件 产品仅供科研

货号：A818244 标准纯度： {[allProObj[0].p_purity_real_show]}
批次查询： 批次纯度:

全球学术期刊中引用的产品

• JACS Au, 2024. Ambeed. [ A148168 ]
• JMC, 2024. Ambeed. [ A187643 ]
• JMC, 2024. Ambeed. [ A341145 , A633512 , A607865 , A167774 ]
• Biomacromolecules, 2024. Ambeed. [ A110759 ]
• Biomacromolecules, 2024. Ambeed. [ A203543 ]
更多 >
产品名称 D1 receptor ↓ D2 receptor ↓ D3 receptor ↓ D4 receptor ↓ D5 receptor ↓ DAT ↓ Dopamine receptor ↓ 其他靶点 纯度
Penfluridol +

Dopamine receptor, Ki: 1.6 μM

 		{[allProObj[0].p_purity_real_show]}
Ansofaxine HCl ++

Dopamine receptor, IC50: 491 nM

 		{[allProObj[0].p_purity_real_show]}
Tetrahydroberberine,THB +

D2 receptor, pKi: 6.08

 		{[allProObj[0].p_purity_real_show]}
Prochlorperazine Maleate ✔ {[allProObj[0].p_purity_real_show]}
Olanzapine ✔ {[allProObj[0].p_purity_real_show]}
Trifluoperazine ++++

Dopamine D2 receptor, IC50: 1.1 nM

 		{[allProObj[0].p_purity_real_show]}
Ropinirole hydrochloride ++

D2 receptor, Ki: 29 nM

 		{[allProObj[0].p_purity_real_show]}
Lurasidone ++++

D2 receptor, Ki: 1 nM

 		{[allProObj[0].p_purity_real_show]}
Levosulpiride ✔ {[allProObj[0].p_purity_real_show]}
Pridopidine ✔ {[allProObj[0].p_purity_real_show]}
Metoclopramide ✔ ✔ {[allProObj[0].p_purity_real_show]}
Molindone HCl ✔ {[allProObj[0].p_purity_real_show]}
Sulpiride ✔ {[allProObj[0].p_purity_real_show]}
Perospirone ++++

D2 receptor, Ki: 1.4 nM

 		{[allProObj[0].p_purity_real_show]}
Perospirone HCl ++++

D2 receptor, Ki: 1.4 nM

 		{[allProObj[0].p_purity_real_show]}
Phenothiazine ✔ {[allProObj[0].p_purity_real_show]}
Pimozide +

Dopamine D1 receptor, Ki: 6600 nM

 		+++

Dopamine D2 receptor, Ki: 3.0 nM

 		++++

Dopamine D3 receptor, Ki: 0.83 nM

 		{[allProObj[0].p_purity_real_show]}
Rotundine ++

D1 receptor, IC50: 166 nM

 		+

D2 receptor, IC50: 1.47 μM

 		+

D3 receptor, IC50: 3.25 μM

 		{[allProObj[0].p_purity_real_show]}
Domperidone ✔ {[allProObj[0].p_purity_real_show]}
ONC206 ✔ {[allProObj[0].p_purity_real_show]}
Pimethixene maleate ++

Dopamine D1 Receptor, pKi: 6.37

 		+++

Dopamine D2 Receptor, pKi: 8.19

 		++

Dopamine D4.4 Receptor, pKi: 7.54

 		{[allProObj[0].p_purity_real_show]}
Loxapine succinate ++

D1 receptor (human), Ki: 26 nM

D2 receptor (Human), Ki: 62 nM

 		++

D2 receptor (bovine), Ki: 26 nM

D2 receptor (human), Ki: 24 nM

 		+++

D4 receptor (human), Ki: 7.5 nM

 		{[allProObj[0].p_purity_real_show]}
Chlorprothixene +++

D1 receptor, Ki: 18 nM

 		+++

D2 receptor, Ki: 2.96 nM

 		+++

D3 receptor, Ki: 4.56 nM

 		+++

D5 receptor, Ki: 9 nM

 		{[allProObj[0].p_purity_real_show]}
SCH-23390 HCl ++++

D1 dopamine receptor, Ki: 0.2 nM

 		++++

D5 dopamine receptor, Ki: 0.3 nM

 		{[allProObj[0].p_purity_real_show]}
MPP+ iodide ✔ {[allProObj[0].p_purity_real_show]}
σ1 Receptor antagonist-1 +

DAT, pKi: 5.8

 		{[allProObj[0].p_purity_real_show]}
Benztropine mesylate ++

DAT, IC50: 118 nM

 		{[allProObj[0].p_purity_real_show]}
Azaperone ✔ {[allProObj[0].p_purity_real_show]}
Ziprasidone HCl ✔ {[allProObj[0].p_purity_real_show]}
Paliperidone ✔ {[allProObj[0].p_purity_real_show]}
Alizapride HCl ✔ {[allProObj[0].p_purity_real_show]}
Amisulpride ✔ {[allProObj[0].p_purity_real_show]}
Quetiapine hemifumarate ✔ Adrenergic Receptor {[allProObj[0].p_purity_real_show]}
Clozapine N-oxide ✔ {[allProObj[0].p_purity_real_show]}
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

Oxidopamine hydrobromide 生物活性

描述 Oxidopamine hydrobromide (6-OHDA hydrobromide), an antagonist of the neurotransmitter dopamine, is a widely used neurotoxin that selectively destroys dopaminergic neurons. 6-OHDA-induced apoptosis of PC12 cells was initiated by superoxide generation followed by caspase cascade activation, which was associated with the suppressed Akt phosphorylation and increased p38 phosphorylation[3]. Moreover, the reduction in proteasomal activity by 6-OHDA was attenuated in SH-SY5Y cells pretreated with 1 μM CA(carnosic acid) [4]. Buspirone improves the anti-cataleptic effect of L-DOPA in a 6-OHDA-induced animal model of PD through the activation of 5-HT(1A) receptors[5].

Oxidopamine hydrobromide 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT01108029 Parkinson's Disease ... 展开 >> Gait Disorders, Neurologic 收起 << Phase 4 Completed - France ... 展开 >> Devos Lille, France, 59037 收起 <<

Oxidopamine hydrobromide 参考文献

[1]Fujita H, Ogino T, et al. Cell-permeable cAMP analog suppresses 6-hydroxydopamine-induced apoptosis in PC12 cells through the activation of the Akt pathway. Brain Res. 2006 Oct 3;1113(1):10-23.

[2]Soto-Otero R, Mendez-Alvarez E, et al. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease. J Neurochem. 2000 Apr;74(4):1605-12.

[3]Fujita H, Ogino T, Kobuchi H, Fujiwara T, Yano H, Akiyama J, Utsumi K, Sasaki J. Cell-permeable cAMP analog suppresses 6-hydroxydopamine-induced apoptosis in PC12 cells through the activation of the Akt pathway. Brain Res. 2006 Oct 3;1113(1):10-23

[4]Lin CY, Tsai CW, Tsai CW. Carnosic acid protects SH-SY5Y cells against 6-hydroxydopamine-induced cell death through upregulation of parkin pathway. Neuropharmacology. 2016 Nov;110(Pt A):109-117

[5]Mahmoudi J, Nayebi AM, Samini M, Reyhani-Rad S, Babapour V. Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats. Pharmacol Rep. 2011;63(4):908-14

Oxidopamine hydrobromide 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.00mL

0.80mL

0.40mL

19.99mL

4.00mL

2.00mL

39.99mL

8.00mL

4.00mL

Oxidopamine hydrobromide 技术信息

CAS号636-00-0
分子式C8H12BrNO3
分子量 250.09
别名 6-Hydroxydopamine hydrobromide;6-OHDA hydrobromide;2,4,5-Trihydroxyphenethylamine;Oxidopamine;6-hydroxy Dopamine;6-OHDA (hydrobromide);6-OHDA
运输蓝冰
存储条件

粉末 Inert atmosphere,Store in freezer, under -20°C

液体 -20°C:3-6个月-80°C:12个月
溶解度

DMSO: 50 mg/mL(199.93 mM)，配合低频超声，并水浴加热至45℃助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

H2O: 20 mg/mL(79.97 mM)，配合低频超声助溶
动物实验配方

Tags: Oxidopamine hydrobromide | 6-Hydroxydopamine hydrobromide;6-OHDA hydrobromide;2,4,5-Trihydroxyphenethylamine;Oxidopamine;6-hydroxy Dopamine;6-OHDA (hydrobromide);6-OHDA | Dopamine Receptor | DAT | AmBeed-信号通路专用抑制剂 | Oxidopamine hydrobromide 纯度/质量文件 | Oxidopamine hydrobromide 亚型比较 | Oxidopamine hydrobromide 生物活性 | Oxidopamine hydrobromide 临床数据 | Oxidopamine hydrobromide 参考文献 | Oxidopamine hydrobromide 实验方案 | Oxidopamine hydrobromide 技术信息

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
    • 客户支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质用途提供服务。

    尊敬的 Ambeed 客户您好，
    请您选择所在区域，我们将转接对应客服为您服务！

    热门区域

    A

    B

    C

    F

    G

    H

    J

    L

    N

    Q

    S

    T

    X

    Y

    Z

    热 A B C F G H J L N Q S T X Y Z